Dupont Capital Management’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Dupont Capital Management’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,000	Closed	-$104K	–	765
2023 Q1	$104K	Hold	10,000	–	–	0.01%	505
2022 Q4	$103K	Hold	10,000	–	–	﹤0.01%	931
2022 Q3	$101K	Hold	10,000	–	–	0.01%	1032
2022 Q2	$100K	Hold	10,000	–	–	﹤0.01%	1179
2022 Q1	$100K	Hold	10,000	–	–	﹤0.01%	1259
2021 Q4	$100K	Buy	+10,000	New	+$99K	﹤0.01%	1288

Dupont Capital Management's LVAC Position: Q2 2023 in Review

Dupont Capital Management sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 10,000 shares — an estimated $104K sold.

Dupont Capital Management first reported a position in LVAC in Q4 2021 and held it in 6 quarters. The position peaked at $104K in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

Dupont Capital Management reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Dupont Capital Management sold 10,000 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $104K.
Dupont Capital Management first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 6 quarters.
Dupont Capital Management's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $104K in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Dupont Capital Management's 13F filing for Q2 2023, filed 25 Jul 2023.